BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND GATA2, NFE1B, 2624, ENSG00000179348, MGC2306, P23769
41 results:

  • 1. Tumor-associated neutrophils upregulate PANoptosis to foster an immunosuppressive microenvironment of non-small cell lung cancer.
    Hu Q; Wang R; Zhang J; Xue Q; Ding B
    Cancer Immunol Immunother; 2023 Dec; 72(12):4293-4308. PubMed ID: 37907644
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer.
    Lee NY; Hum M; Zihara S; Wang L; Myint MK; Lim DW; Toh CK; Skanderup A; Samol J; Tan MH; Ang P; Lee SC; Tan EH; Lai GGY; Tan DSW; Yap YS; Lee ASG
    Hum Genomics; 2023 Jul; 17(1):66. PubMed ID: 37461096
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. gata2 Deficiency: Predisposition to Myeloid Malignancy and Hematopoietic Cell Transplantation.
    Rajput RV; Arnold DE
    Curr Hematol Malig Rep; 2023 Aug; 18(4):89-97. PubMed ID: 37247092
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Influence of Genetics on the Response to Omalizumab in Patients with Severe Uncontrolled Asthma with an Allergic Phenotype.
    Rojo-Tolosa S; Sánchez-Martínez JA; Pineda-Lancheros LE; Gálvez-Navas JM; González-Gutiérrez MV; Jiménez-Gálvez G; Pérez-Ramírez C; Morales-García C; Jiménez-Morales A
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108192
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Association of pulmonary nontuberculous mycobacteria with the outcomes of patients with lung cancer: A retrospective matched cohort study with a special emphasis on the impact of chemotherapy.
    Liao TY; Wang JY; Shih JY
    J Microbiol Immunol Infect; 2023 Apr; 56(2):392-399. PubMed ID: 36456443
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. cancer cell-derived exosomal miR-425-3p induces white adipocyte atrophy.
    Liu A; Pan W; Zhuang S; Tang Y; Zhang H
    Adipocyte; 2022 Dec; 11(1):487-500. PubMed ID: 35941833
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. LINC00891 regulated by miR-128-3p/gata2 axis impedes lung cancer cell proliferation, invasion and EMT by inhibiting RhoA pathway.
    Zhang Y; Song D; Peng Z; Wang R; Li K; Ren H; Sun X; Du N; Tang SC
    Acta Biochim Biophys Sin (Shanghai); 2022 Mar; 54(3):378-387. PubMed ID: 35538035
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches.
    Ahmed FF; Reza MS; Sarker MS; Islam MS; Mosharaf MP; Hasan S; Mollah MNH
    PLoS One; 2022; 17(4):e0266124. PubMed ID: 35390032
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Histologic transformation of epidermal growth factor receptor-mutated lung cancer.
    Fujimoto D; Akamatsu H; Morimoto T; Wakuda K; Sato Y; Kawa Y; Yokoyama T; Tamiya M; Hiraoka R; Shingu N; Ikeda H; Tamiya A; Kanazu M; Miyauchi E; Miura S; Yanai M; Yomota M; Morinaga R; Yokoi T; Hata A; Suzuki H; Matsumoto H; Sakata S; Furuya N; Harutani Y; Nakachi I; Otsuki A; Uematsu S; Hara S; Yokoo K; Sugimoto T; Yamamoto N
    Eur J Cancer; 2022 May; 166():41-50. PubMed ID: 35278824
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Therapeutic options for CTLA-4 insufficiency.
    Egg D; Rump IC; Mitsuiki N; Rojas-Restrepo J; Maccari ME; Schwab C; Gabrysch A; Warnatz K; Goldacker S; Patiño V; Wolff D; Okada S; Hayakawa S; Shikama Y; Kanda K; Imai K; Sotomatsu M; Kuwashima M; Kamiya T; Morio T; Matsumoto K; Mori T; Yoshimoto Y; Dybedal I; Kanariou M; Kucuk ZY; Chapdelaine H; Petruzelkova L; Lorenz HM; Sullivan KE; Heimall J; Moutschen M; Litzman J; Recher M; Albert MH; Hauck F; Seneviratne S; Pachlopnik Schmid J; Kolios A; Unglik G; Klemann C; Snapper S; Giulino-Roth L; Svaton M; Platt CD; Hambleton S; Neth O; Gosse G; Reinsch S; Holzinger D; Kim YJ; Bakhtiar S; Atschekzei F; Schmidt R; Sogkas G; Chandrakasan S; Rae W; Derfalvi B; Marquart HV; Ozen A; Kiykim A; Karakoc-Aydiner E; Králíčková P; de Bree G; Kiritsi D; Seidel MG; Kobbe R; Dantzer J; Alsina L; Armangue T; Lougaris V; Agyeman P; Nyström S; Buchbinder D; Arkwright PD; Grimbacher B
    J Allergy Clin Immunol; 2022 Feb; 149(2):736-746. PubMed ID: 34111452
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pulmonary Manifestations of gata2 Deficiency.
    Marciano BE; Olivier KN; Folio LR; Zerbe CS; Hsu AP; Freeman AF; Filie AC; Spinner MA; Sanchez LA; Lovell JP; Parta M; Cuellar-Rodriguez JM; Hickstein DD; Holland SM
    Chest; 2021 Oct; 160(4):1350-1359. PubMed ID: 34089740
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. High penetrance of myeloid neoplasia with diverse clinical and cytogenetic features in three siblings with a familial gata2 deficiency.
    Ellingford JM; Telford N; Urquhart J; Will AM; Bonney D; Adams B; Dixon R; Kerr B; Black GC; Wynn RF; Meyer S
    Cancer Genet; 2021 Aug; 256-257():77-80. PubMed ID: 33957466
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma.
    Zhai Y; Zhao B; Wang Y; Li L; Li J; Li X; Chang L; Chen Q; Liao Z
    BMC Cancer; 2021 Mar; 21(1):213. PubMed ID: 33648465
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Sequencing of RNA in single cells reveals a distinct transcriptome signature of hematopoiesis in gata2 deficiency.
    Wu Z; Gao S; Diamond C; Kajigaya S; Chen J; Shi R; Palmer C; Hsu AP; Calvo KR; Hickstein DD; Holland SM; Young NS
    Blood Adv; 2020 Jun; 4(12):2656-2670. PubMed ID: 32556286
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A MYC target long non-coding RNA gata2-AS1 regulates non-small cell lung cancer growth.
    Zhang L; Gao L; Shao M; Sun GY
    Neoplasma; 2019 Nov; 66(6):954-962. PubMed ID: 31607132
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The Transcription Factor ERG Regulates Super-Enhancers Associated With an Endothelial-Specific Gene Expression Program.
    Kalna V; Yang Y; Peghaire CR; Frudd K; Hannah R; Shah AV; Osuna Almagro L; Boyle JJ; Göttgens B; Ferrer J; Randi AM; Birdsey GM
    Circ Res; 2019 Apr; 124(9):1337-1349. PubMed ID: 30892142
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. MDS-associated mutations in germline gata2 mutated patients with hematologic manifestations.
    McReynolds LJ; Yang Y; Yuen Wong H; Tang J; Zhang Y; Mulé MP; Daub J; Palmer C; Foruraghi L; Liu Q; Zhu J; Wang W; West RR; Yohe ME; Hsu AP; Hickstein DD; Townsley DM; Holland SM; Calvo KR; Hourigan CS
    Leuk Res; 2019 Jan; 76():70-75. PubMed ID: 30578959
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. gata2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells.
    Jung M; Cordes S; Zou J; Yu SJ; Guitart X; Hong SG; Dang V; Kang E; Donaires FS; Hassan SA; Albitar M; Hsu AP; Holland SM; Hickstein DD; Townsley D; Dunbar CE; Winkler T
    Blood Adv; 2018 Dec; 2(23):3553-3565. PubMed ID: 30538114
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genomic alterations of plasma cell-free DNAs in small cell lung cancer and their clinical relevance.
    Du M; Thompson J; Fisher H; Zhang P; Huang CC; Wang L
    Lung Cancer; 2018 Jun; 120():113-121. PubMed ID: 29748005
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. E-26 Transformation-specific Related Gene Expression and Outcomes in Cytogenetically Normal Acute Myeloid Leukemia: A Meta-analysis.
    Fang JF; Yuan HN; Song YF; Sun PB; Zheng XL; Wang XJ
    Chin Med J (Engl); 2017 Jun; 130(12):1481-1490. PubMed ID: 28584213
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.